Juan Mestre

2.3k citations
27 papers · 2.0k indexed · h-index 19
Topics
Inflammatory mediators and NSAID effects (16 papers)Estrogen and related hormone effects (11 papers)Eicosanoids and Hypertension Pharmacology (3 papers)
Partner nations
United StatesJapanSpain

In The Last Decade

Juan Mestre

26 papers receiving 1.9k citations

Peers

Juan Mestre
Comparison fields: 5 of 109
  • Pharmacology 782
  • Molecular Biology 625
  • Genetics 398
  • Oncology 359
  • Cancer Research 283
Replace Won‐Ki Baek with:
Won‐Ki Baek South Korea
Kazunori Fukuda Japan
Somasundaram Arumugam Japan
Seong‐Il Suh South Korea
Mun-Ock Kim South Korea
Ming‐Ju Hsieh Taiwan
Zhifeng Wei China
Saverio Bettuzzi Italy
Young‐Rae Lee South Korea
Jer-Yuh Liu Taiwan
Juan Mestre relative to Won‐Ki Baek South Korea Won‐Ki Baek's profile →
Citations per field
00.5×5.5×
Won‐Ki Baek · 1×
Citations per year

Countries citing papers authored by Juan Mestre

Since Specialization
Citations

This map shows the geographic impact of Juan Mestre's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Juan Mestre with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Juan Mestre more than expected).

Fields of papers citing papers by Juan Mestre

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Juan Mestre. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Juan Mestre. The network helps show where Juan Mestre may publish in the future.

Co-authorship network of co-authors of Juan Mestre

This figure shows the co-authorship network connecting the top 25 collaborators of Juan Mestre. A scholar is included among the top collaborators of Juan Mestre based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Juan Mestre. Juan Mestre is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 2
3 36
4 64
5 8
6 18
7 37
8 36
9 134
10 21
11 20
12 72
13 42
14
Thalidomide and its analogues inhibit lipopolysaccharide-mediated Iinduction of cyclooxygenase-2.
109
15 28
16 247
17 297
18
Inhibitory effects of caffeic acid phenethyl ester on the activity and expression of cyclooxygenase-2 in human oral epithelial cells and in a rat model of inflammation.
334
19 8
20
Retinoids suppress epidermal growth factor-induced transcription of cyclooxygenase-2 in human oral squamous carcinoma cells.
127

About Juan Mestre

Juan Mestre is a scholar working on Pharmacology, Biochemistry and Genetics, having authored 27 papers that have together received 2.0k indexed citations. Recurring topics across this work include Inflammatory mediators and NSAID effects (16 papers), Estrogen and related hormone effects (11 papers) and Eicosanoids and Hypertension Pharmacology (3 papers). The work is most often cited by research in Pharmacology (782 citations), Molecular Medicine (177 citations) and Cancer Research (283 citations). Juan Mestre has collaborated with scholars based in United States, Japan and Spain. Frequent co-authors include Andrew J. Dannenberg, Kotha Subbaramaiah, Nasser K. Altorki, Tadashi Tanabe, Philip P. Stapleton, Peter G. Sacks, J.M. Daly, Wen Jing Chung, Fan Zhang and Peter J. Mackrell. Their work appears in journals such as Journal of Biological Chemistry, FEBS Letters and Annals of the New York Academy of Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026